“Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders” (2002) Swiss Medical Weekly, 132(2930), pp. 414–414. doi:10.4414/smw.2002.10031.